Apple’s Device Delay… And Vaccine Makers Under Pressure 9/12/25

12 Sep 2025 · 44 min

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Podcast Notes: CNBC's "Fast Money" - Episode: Apple’s Device Delay… And Vaccine Makers Under Pressure (9/12/25)

Podcast Overview

  • Host: Melissa Lee
  • Description: "Fast Money" delivers actionable news and insights for investors, breaking through daily market noise. Airs weeknights at 5 PM ET on CNBC.

---

Episode Summary This episode discusses Apple's recent challenges, specifically the delay in launching the iPhone Air model in China due to regulatory issues, and the pressure on vaccine manufacturers following new reports linking child deaths to COVID vaccines.

Key Topics Discussed

  1. Apple's iPhone Launch Challenges
  2. Delayed Shipments: Apple faces delays for the iPhone Air, particularly in China, due to regulatory approvals for selling the device.
  3. Analyst Expectations: Discussion on how the delays might indicate high demand, contrasting last year's disappointing performance where shorter wait times were seen as negative.
  4. Market Reactions: Apple's stock performance has been lackluster since the announcement of the new iPhone, leading to discussions on future stock predictions from analysts.
  1. Vaccine Manufacturers Under Pressure
  2. New Reports: The Trump administration is reportedly linking child deaths to COVID vaccines, impacting stocks of Pfizer, Moderna, and other vaccine makers.
  3. Market Impact: Shares of major vaccine manufacturers dropped sharply, with discussions around how public perception and regulatory scrutiny might affect future sales.

---

Detailed Discussion Points

Apple’s Device Delay

  • Launch Day Insights:
  • Pre-orders for new iPhones began with mixed results. Some models faced shipping delays, which analysts view as an indicator of demand.
  • Regulatory hurdles in China have delayed the sale of the iPhone Air, raising concerns about Apple's market share in a key region.
  • Analyst Predictions:
  • Steve Kovach, a tech analyst, mentioned that longer delivery windows can be a positive indicator of strong demand.
  • Analysts are closely watching how these delays influence Apple's stock and market perception, with targets suggested around $270 - $400 depending on AI advancements and broader adoption.
  • Shifting Focus:
  • Apple’s pivot away from AI development towards enhancing product offerings is viewed positively, as it aligns with consumer demand for innovative gadgets.

Vaccine Makers Under Pressure

  • Regulatory Concerns:
  • Reports of adverse effects related to COVID vaccines are causing significant market reactions, particularly affecting Pfizer and Moderna stocks.
  • Analysts suggest these regulatory issues could have broader implications for public health and vaccine uptake.
  • Market Sentiment:
  • The discussion highlighted the growing concerns over vaccine safety and how it could lead to lower vaccination rates in children, further complicating the recovery for vaccine manufacturers.
  • Investor Sentiment:
  • Analysts noted a cautious approach from investors, with sentiments reflecting negativity towards the vaccine sector amidst emerging concerns.

---

Key Takeaways

  • The delay in the iPhone Air’s launch due to regulatory issues signals significant demand but also market vulnerabilities for Apple.
  • The new scrutiny on vaccine safety in light of reports could destabilize market confidence in major pharmaceutical companies, impacting share prices.
  • Analysts continue to differ on their outlooks for Apple, with many cautiously optimistic based on demand metrics, while the vaccine market faces increasing scrutiny and public hesitance.

---

Final Remarks This episode of "Fast Money" encapsulates the intersection of technology and healthcare markets, emphasizing how regulatory challenges and public perception can dramatically influence investor sentiment and stock performance. The discussions around Apple's strategic pivots and vaccine manufacturers' vulnerabilities provide a nuanced view of today's market landscape.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:00Hi, it's Melissa. Before we jump into today's show, I've got something exciting to share. On December 11th, we are hosting a special edition of Fast Money Live. trading the holidays right here at the Nasdaq Market Site. You get to watch a live taping of Fast Money, meet and interact with the traders, and of course, celebrate the holiday season with us. It's stocks and cheers in the heart of the city, Times Square in December. You will not want to miss this. Tickets are available now at CNBCEvents.com slash Fast Money. Live in the Nasdaq Market Site in the heart of New York City's Times Square, this is Fast Money.

0:31Here's what's on tap tonight. Apple's big day. The company's latest iPhones now available for pre-order, but could report the delayed shipments way on the stock. We'll talk to one top analyst. Plus, Tesla revs up. The stock locking in its best week since May, but the chartmaster thinks the rally is about to run out of gas. He'll tell us why. And the Winklevoss' Gemini makes its market debut. Pfizer and Moderna sink on new concerns over their COVID vaccines. And not a meme stock, what Opendoor's co-founder had to say about the surge in shares of the online real estate stock. I'm Melissa Lee. I'm to you live from Studio B at the NASDAQ.

1:05On the desk tonight, Tim Seymour, Karen Feinerman, and Carter Braxton Wirth. We start off with Apple trying to stage a rebound to close out the week. The stock dropping almost 2 % today, but still down 2.3 % since announcing its latest iPhone on Monday. That makes it the worst performer among the Mag 7 this week. Pre-orders for the new devices went live today with reports that some Pro Max models were already seeing delays in their delivery windows. Reports also that the super thin iPhone Air could be delayed in China due to regulatory concerns. For the latest, we're joined here on set by Steve Kovach, who was right there when the thing was unveiled.

1:38What are you hearing so far? Yeah, so it's actually a pretty smooth launch today so far. I'm old enough to remember when the site would collapse every day the pre-orders would start for the iPhone. But here's the good news. Those delays that you were talking about in the iPhone Pro, that's actually good. That means the lead time is getting longer. That means demand is high. When we wake up Monday morning, we're going to have in our inbox a slew of notes from all the Wall Street analysts kind of picking apart what the delay and what the time looks like. Because the bigger that window is, that's the first read we get as to what the demand looks like.

2:10Last year was a disappointing year. We saw those windows shrink, which is actually bad. Yes, people get their phones faster. But for Apple, that's a bad signal. So we're going to want to see longer wait times for these. Now, on the iPhone Air front, as you mentioned, that is not for sale in China. This was unexpected. We woke up today thinking it would go on sale, but actually there's some regulatory issues going on. The wireless carriers out there do not yet have the government's approval to sell this phone with the new kind of SIM card they're using. It's called an eSIM. They do have the approval to sell the other three iPhone models, the 17, 17 Pro and 17 Pro Max.

2:46So those are going smoothly. Apple tells me they're going to get it on sale in China as soon as they can. But this is probably the hottest device in this cycle right now. It's the same price as the Pro was last year. That is, increases those average selling prices on phones. Very important. And by the way, if you want to hear more about these phones, our own Jim Cramer has an exclusive interview coming up next hour on Mad Money with Apple CEO Tim Cook live from that Corning Glass factory down there in Kentucky. So a lot more to unpack there with Mr. Cook. Yeah, and we saw little clips of it during the day.

3:19Yes. Tim Cook turning the iPhone Air to its side, saying, you can barely see this, can you? You can see it. And then holding it. I know. I was like, I could see that plain as day. And then holding it, saying, we're holding the future in our hand. But I think he's not being, he's kind of exaggerating and playing Mr. Marketer there a little bit. But at the same time, this is what I've been saying all week. This is Apple going back to what it's good at, making really cool, desirable gadgets, not focusing on artificial intelligence and software and services, which they've been historically weaker at, they are going to really make these devices that people want to go out there and buy.

3:53This is an attractive device. This is going to creating a lot of excitement. I was out there in Cupertino earlier this week. One of the top iPhone executives, I was talking to her. She's using the iPhone Air. Tim Cook was using the iPhone Air. It's not even the best phone they make, but it's that kind of attractive device that's getting people really excited. So, Steve, do you sense that Tim Cook and Apple are kind of, you know, they're not doing, They actually believe that this is about the innovation, both in the design body and a better camera and the things that historically have made this a cool phone.

4:23And they've not been innovators. And so it's kind of as everyone's doing AI, they're saying, look over here. And do you think that that's really what do you think there's a game of misdirection, not outwardly, as they would put it? Or do you really think that they believe they've delivered a phone here that is as good as they have released ever in terms of and in terms of what's expected of them? in this environment yeah i think i think it yeah the short answer is yes the longer answer is let's talk about the install base too we see them sitting out artificial intelligence this year that is so true understood but making the cool phones people want to buy just keeps that ecosystem rolling one billion plus iphone users in the world what ai company wouldn't want access to those customers so as apple pivots away from building artificial intelligence in-house to partnering with a google or an open AI or an anthropic, whoever it might be, they are in a better position now to do that.

5:17Just today, we got news that another AI executive, Bloomberg reported, is leaving Apple. I mean, I can't even keep track of how many of these people have left the company. It's almost like it's good news. And they're going to be able to do it in a cheap, assuming they can pull off what they say they can now pull off. They're going to be able to do it in a cheaper way. They're not spending$100 billion a year on CapEx and building these data centers. They're not spending$100 million going out there poaching talent from open AI and rivals. They're letting their talent leave, in fact, so they can do what they're good at, which is making cool phones people want to buy.

5:50Right. Steve, thank you. Good to see you. Steve Kovac. It's interesting how we sat on the desk the day of the Apple event and we said, you know what, this is just a thinner phone. And then the narrative has sort of changed here. And I'm just wondering if you agree with that change. I'm a little surprised, actually. I figure so you're talking about, all right, they don't need to build it in-house, but they know they need it, right? So why wouldn't you wait until they have it to get a phone that incorporates it? It's Friday afternoon. Can I throw a flag on Karen? Who brought the guest back? You brought the guest back.

6:18Oh, we're not supposed to do that? I don't know. He's sort of, all right, sorry. Am I technically a guest if I collect a paycheck from this place? That's right. Yeah, we'll let that go. All right, sorry. Thanks, Tim. You're in trouble with the teacher. Go ahead. I was never that guy, by the way. It was always happening to me. I believe you. It was always happening. But are you, I mean, do you think the narrative has changed? It's like all of a sudden Apple's back in the game, innovating, making cool phones that people want. Well, as the guy on the desk who's long and who've kind of defended Apple for not having to be an AI and that being focused on an install base and being focused on the fact that if anything, you know, the Craig Moffitt argument earlier in the week, which is that we've removed more China uncertainty.

6:59They're never going to make major components in the U.S. Craig's gone out of his way to say, I'm not gangbusters bullish, but bears have kind of converted. Tim Cook has done masterclass work with the White House. Apple has a cool product. Everybody here on this desk probably has to get a new phone sometime in the next year or two. I mean, mine is barely working. And the fact is they're going to be serving up AI through whether it's Google, Gemini, whether it's Dynamics in terms of partnerships, whether it is their ability to actually do multiple deals. I don't know what they're going to do, But I don't think that we should be surprised that people are finally saying no good news was priced in.

7:39That's good for the stock now. Well, a couple of things for. Except Carter. And then we can get to how long, how often are you supposed to replace them? And with four kids, they break. I think I'm getting them sort of. Yeah, I mean, they're coming into my household every three to four months. It's crazy. But anyway, one, we're on the three year anniversary of its relative peak to the sector. Right. So that was in it was in September of 2022. The second thing that's important, of course, is that Apple showed a little bit of life over the past month and a half, but it's precious little. Right off of its April low, it's up 38 percent.

8:08The tech sector is up 58 percent, which leaves the stock still down on the year and 10 percent below its Christmas peak. Do you fade this move? I think you do. Well, I'm not really long. So, yes, I agree. I mean, also, I come into valuation. You know, we looked at this very differently, but end up in a similar place. It's expensive. And I don't really see the catalyst. This, to me, was not the catalyst. Do they have any earnings growth out of the buyback? I mean, the EPS is one thing. When you're buying back at north of 30. No, but without the buyback, is their net income growing? Yes. Barely.

8:40Right, but not in the buyback for a long time was a tremendous thing to do. It would be great if we had an analyst coming on the desk to talk about it. It would be very handy. Someone just settled who could just slip right in. One wishes Dan Ives out with iPhone 17 pre-order predictions in a new note today. Dan is here. He is the firm's global head of technology research. Dan, good to have you with us. Great to be here. What are you hearing right now about demand for this phone? I think Air, definitely, that's been the upside. I think that's what you've seen. You know, in terms of what I believe is going to be the pre-order activity, probably about 5%, 10 % year over year is what we're looking at for iPhone 17 over iPhone 16.

9:14Plus, clearly, China, you know, that's the X variable, right? I mean, you had this little sort of dent relative to the regulatory. But I think overall, Sheree's expectations definitely are probably too conservative going into this launch. I mean, I think the streets, like 30 percent holds or something like that, which has got to be sort of a historic low. And this is historically a stock that is well-liked on the street. So do things line up, I mean, right now for just sort of that bounce in your view? I think Karen makes a great point in terms of just some of the worries here when it comes to AI.

9:45But I think there's three things. One, New York City cab driver is bearish in Apple right now. So I think the sentiment overall is, one, street's very negative. Number's going to have to come up. And I think as you have number of visions higher, that's bullish in terms of for Apple. Two, look, when it comes to AI, there's a better chance of me playing in Ryder Cup, Beth, P, H, September than anything happening internally at Apple. So I think now streets recognize it's going to have to come external. Looks like Google Gemini is going to be the way. And the third thing is, look, Cook's played nice in the sandbox in D.C.

10:16So in terms of the tariff sort of dance that he's done, that's been a positive. You set that all up. I think, you know, 270 is our price target book. To have a$350,$400, AI will be that magic sort of wand that needs to happen. Okay, so when is that likely to happen? It seems to me like this iteration isn't going to be the one that's going to. So does it really even matter now what happens here? Look, I think it does matter relative to. You cannot be on the outside looking at the biggest, whatever is the fourth industrial revolution every tech company is going after. But I do think the best thing that happened to Apple was that DOJ positive for Google because that finally reignited the candlelight dinner between Sundar and Cook, probably happening soon, to double down that partnership.

11:07But what's baked in here is Street viewed this as this was going to be a 4 % to 5 % grower from an iPhone unit perspective. Now looking likely, we'll see our trajectory looks like, probably 7%, 8%. The other thing is, based on our estimates, 315 million iPhones have an upgrade in four plus years of 1.5 billion iPhones. So you do have a lot of pent up demand there. And I think that speaks to probably a stock that looks like it's going to move higher over the coming weeks and months. By the way, Dan, I think you could probably make the Ryder team with that jacket. I mean, there's no question that they're looking for some fashion flair.

11:42I just wish I had a short game to match it. Well, Keegan Bradley, by the way. We're not talking about it. Let's talk Apple. But when you were on a month ago, you made the sense that there was an imperative. They did something very quickly. I remember you saying six months or they're dead in the water. And we maybe we framed it this way, but it was kind of like, is this their BlackBerry moment? And I don't know that it were any different than we were six months ago, but you seem more confident. And that that makes sense to me, because I just think that the couple of things that have happened for Apple in terms of China, in terms of Trump, in terms of dynamics are enough.

12:14But has something changed for you? It's the Google DOJ. I mean, the Google DOJ ruling, ironically, AI is ultimately what really got the win there. That opens the lane. Now, it's not about buying perplexity. It's not about an acquisition. Now, that is going to double down. So you don't need to see, because, again, you needed to see something. Because the reality was you thought that they were going to be hands high behind their back. They couldn't ultimately do anything with Google. Now, that opens it up. So you think about this good news. First, it was obviously Cook in the Belly and Oval Office.

12:44what he's done with Trump in terms of White House and investing from an AI perspective, Kramer being there at the factory. Then you now look at the DOJ. That was a champagne moment. Then you actually have, when you look at air and what looks like the demand trajectory here, better than expected. Look, combo that with sentiment that's so negative, at least institutionally speaking on Apple. I think that's a really good setup, in my opinion. So walk us through the catalyst. And I think this gets to Karen's question. We were expecting an update to Siri right early next year. I mean, are you expecting that some sort of a deal with Google would happen by then?

13:20Yeah, I believe it. Okay, so that's going to be the same thing. I believe deal with Google. We're not going to have to wait until WWDC in June. A deal with Google happens before year end. I think that's something that gets announced in terms of at least the initial framework of what that deal looks like. That's the important thing because to Karen's point, there's no magic solution here that's going to be AI driven. But if the street realizes, OK, here this is going to be an 8.5 and a 10 of a cycle relative to iPhone. But then you actually have over the next year the real one, the one that's going to be the game changer.

13:52That's where I think sentiment really starts to change relative to the stock. Just another question about the DOJ. So we know that that relationship is allowed, but other relationships are also allowed. Do you see any other any other player doing a big deal? Or does it feel like that pole position is so important that the next one isn't worth however many billions it would be? I think they just need each other both so much. And the reality is that$20 billion probably goes to$30 billion or more when that re-ups, you know, because it's going to be a much bigger deal. And then when it comes to Apple, they don't really want to be forced into a perplexity deal.

14:27So they're going to need Google. And now look, could Google go outside? of course, but they know that red phone hits Cupertino and Cook because they need them from an install base that's unparalleled. Even though it's not exclusive, that's more sort of, you know, from a quote perspective, because the reality is it is semi-exclusive. Dan, great to see you. Thank you. Dan Ives of Wedbush. Have you gotten more bullish since Monday? No, I think I'm where I have been. And I've had to sit and fight my corner on I don't think there's any good news in the stock. And the multiple doesn't bother me in a market that doesn't care about the multiple.

15:04And as we as smarter people than me have said, the higher multiple is not going to sink this market. It's not going to sink Apple either. And so I believe that they are going to serve up A.I. with great deals, probably a better deal to have Google Gemini or possibly one of the other folks. And I do think that there is an element of their services business that's probably underappreciated. I think they're going to find a way to get that to be more than a 15 percent part of the revenue stream. And buybacks and things that have made Apple a defensive company or at least a company that investors shouldn't be running too far away from.

15:36I mean, that's always been there. Yeah. I mean, the knock on the valuation is a real one. I mean, especially when you compare it to a Meta or an Alphabet, which have lower PEs, higher growth. I mean, they are more like growth stocks now. Despite the Google re-rating, it's still significantly lower, mid-20s versus low-30s. Which chart looks the best? I mean, of those, let's go with Google first. That's extended now. Okay. Harvest a little bit. The one that hasn't done that, you know, Oracle's just done that, closed very poorly today. The one that really hasn't broken out of the two, well, two, both Amazon and Meta.

16:10They are basically toying with their February highs, a little bit above, a little bit below. I think those are better than a lot of the extended ones. All right. And another reminder here, do not miss Jim Cramer's full interview with Apple CEO Tim Cook. That's at the top of the hour on Mad Money. Well, a wild week for Opendoor, even with today's 14 % loss. The real estate stock is up 36 % this week and almost 470 % this year. Shares jumping yesterday after announcing a new CEO and that co-founder Keith Raboy would return to the company as board chair. Raboy joining Squawk in the Street today commenting on recent retail trader interest in Opendoor and said it is not a meme stock.

16:49What do you do, though, with a meme stock? I mean, it's up 1 ,500. It's not a meme stock. It's not a meme stock. So let's talk about what this means. Wait, look. Well, let's talk about this. What is the entire original point of having markets? It's to allocate capital, right? First principles. Markets are designed to allocate capital. Consumers are voting with their feet to say, we want more capital being allocated to Opendoor. That's a good thing. That's how society should work. You must have upset that base of retail investor by saying that, really denouncing the term name stock. I mean, a lot of companies become one or not, whether or not they participate in it.

17:34Right. I mean, to me, it does seem very mean. Yesterday you had over the entire float trade, well over the entire float trade. Now, obviously, things can trade multiple times, but that to me would be a sign, for example. and, you know, the wild swings in valuation. Whatever, it doesn't matter. If they can create value, they can create value. I think I saw you earlier today talking about, well, Carvana was meme-y. Right. And now it's not graduated into a non-meme. So you're not saying it can't happen, but this does seem meme-y to me. Yeah. Yeah, I think that's true. We've seen that with a few companies.

18:06You can make an argument that Robinhood's gone that way, too. But, you know, ultimately, what does this company do? I mean, if we're going to get at the definition of what a meme stock is, it's something that gets caught up in hysteria, especially because the stock was down and out. And that gives an opportunity for people either to say, all right, what were meme stocks? Meme stocks during COVID were seemingly stocks that were broken companies that seemingly had big short interests. And there was a group of people that were trying to be opportunistic to say we can either squeeze people that have that short interest or we can actually get behind a company that we think is changing.

18:42I think, you know, look at AMC and look at an example of people that got so confused to try to believe that this company, suddenly the fundamentals around their core business were going to change just because there were a lot of, I would call those capital markets hieroglyphics. And therefore, you know, it may be good in the short run. There may be an opportunity. And let's see what happens to GameStop. I mean, it's really still an open issue. I mean, the key is short run, right? This is very much something to train if you're going to do it. You know what you're doing, right? You're engaging in something that is highly volatile.

19:13That is what? How would I write the article? Open, down 98 % from its high of two years ago. It's now down only 76%. I mean, it's like, so what, right? But that doesn't mean you can't trade and make money. So here and now, it's in play, and I guess I'd be long. Be long. Be long, wow. Coming up, a retail route. The new data weighing in consumer discretionary names today is retailers gear up for the holidays. That's next. Plus, another IPO pop, the Winklevoss founded crypto company Gemini, making its market debut. The move in that name and how the rest of crypto fared this week. Don't go anywhere.

19:48Fast Money's back in two.

19:58Welcome back to Fast Money Retail. Under pressure today, Abercrombie, Gap, Lulu and Dix, just some of the names deep in the red. That after the latest read on consumer sentiment dropped to its lowest level since May. Karen, you flagged this. I mean, we're going into the holiday season. We just came off of back to school, and they're not performing well. The stocks aren't performing well. I mean, we did have that sentiment number, which you can think of as something that this group of stocks would be very sensitive to. So I don't know if that's what happened. I mean, I find it interesting when all different kinds of retailers and all different kinds of space, they're all down.

20:30Even like TJX, which usually does better relatively. And Amicrobby not doing well at all. Nike as well, long that, long TJ, long some Gap. Difficult day, but I think I saw a lot of good retail stuff. Last night, RH was a different story. Right. Different kind of buyer, much more expensive items. But I am still positive on the retailer. Are you? Well, that's just one way to look at it is if you look at the XRT, which is that equal weight retail ETF, which has about 150 names. Could be Monroe Muffler up to Amazon. They're all equal weight. The Monro Muffler Yeah It's in there Who knew Who knew The point is I was trying to pick Something arbitrary And unknown I think I succeeded At that Okay So this ETF Is highly correlated With the Russell 2000 Right Because it's equal It's got about A 70 % correlation It's come a long way Right I mean Just as the Russell 2000 And my hunch is You're starting to see Cracks now Right You're seeing Individual names Are peeling away Yes there's the Ralph Lauren's that are continuing, but generally speaking, it would fade this area.

21:38I mean, just so what Karen was doing in terms of connecting it to other consumer-facing names, you can connect this also to the restaurant trade. I mean, it's a lot of similar sort of characteristics. It's a very tough situation right now for Cava, Sweet Green, CMG. Yeah, exactly. I think this is a combination of quietly you've had consumer discretionary as a group be third in line after tech and communications. And so the group has generally done well. When you look at Lulu, Lulu hasn't done well for a long time. Nike, outside of a couple spurts, hasn't done well for a long time. Cracks in the TJ Maxx kind of armor are things that are worth watching because this thing's been bulletproof for many different cycles.

22:19But I think if you think about consumer discretionary, there are places here that I don't want to be. I don't really want to be in discretionary apparel, especially in places where we've had big thematic or big kind of dynamics around. I think athleisure is a place to be wary. I'm a long Nike, but I'm a long Nike because I think Nike's gone through this period and I think Nike's not expensive. But I think consumer discretionary. And is one Michigan or consumer confidence number enough to start selling off discretionary? Absolutely not. Remember how wrong the soft data has been. But I think there are parts of discretionary that are no touch.

22:55There's a lot more Fast Money to come. Here's what's coming up next. Crypto back in the spotlight. A Winklevoss-founded crypto exchange, the latest name to make its public debut. How it fared and whether Bitcoin's momentum can continue after a big week of gains. Plus, more concerns for vaccine makers on a new report on the HHS. The potential moves from the Trump admin weighing on those names. You're watching Fast Money, live from the NASDAQ market side in Times Square. We're back right after this.

Read the full transcript

23:37Welcome back to Fast Money. Shares of Winklevoss founded Gemini Space Station, jumping more than 14 % in its market debut today. The crypto company, which priced above its expected range at$28, opened around$37. The move comes amid a big week for crypto. Bitcoin up more than 4%, Ether down nearly 8 % higher, and Solana way outperforming, up nearly 17 % here. Big week for IPOs, big week for crypto, all of that positive. Look, it's been this week. I know there was a lot of themes this week, but the one I think is the most important is this was IPO Bonanza Week, and there was$4 billion in new product and whatnot.

24:12I do think, though, this Gemini IPO is important. I think, first of all, I give the Winklevoss twins a lot of credit for hanging in there through a lot of difficult times. And this this was way oversubscribed. And I do think that if you think of where they were talking, price range was 17 to 19, comes to 28, trades higher. I mean, this is the institutional interest. And I've spoken to folks at the company. And, you know, the bottom line is after years of going around to get institutional sponsorship, now institutional sponsorship is there. And I think even when and if there's there's eventually, There will be a change even in Washington.

24:48I think the progress that crypto has made under the Trump administration, there's no putting the genie back in the bottle. Institutional follow through here is clear and they're out there. And I think this is out there and going higher. By the way, there's a heavy retail allotment here in this idea, 30 percent. Goes to hood. Yeah, exactly. Right. So they totally embrace the role of the retail investor in the making of not just the crypto trade. I mean, enduring all those crypto winters that they went through, but also in the interest in their stock. In the equity trade. Yeah, exactly. Yeah, it's interesting, though.

25:19I look at the space, you know, we looked at bullish, which, you know, opened and traded up to 118. I forget exactly the offer price and is now not quite at the low. Yeah, just about at the low since then at 51 and change. So this, you know,$4 on 28 is not terrible. but I think it's actually a little bit underwhelming. I agree with Tim that I think the most notable thing, at least for any investment banking group, right, Goldman Sachs, J.P. Morgan, all of them, Bank of America, Wells, and Citi, this activity is really good activity. We're here. Yeah, definitely. Just quickly on the crypto, like which chart looks the best right now?

26:03Yeah, I mean, the best trade, of course, has been Ethereum catching up to Bitcoin. That has happened, and now it's back to its highs of four or five years ago, whereas Bitcoin is gradually making new highs. I like them both here for generally higher prices. All right. Coming up, a new report hitting shares of Pfizer and Moderna today. The potential news out of the Trump administration that could take a toll on the vaccine industry. Those details next.

26:34Welcome back to Fast Money. Stocks closing mixed to end the week. The Dow falling 273 points. The S &P virtually flat. The Nasdaq of more than four-tenths of a percent, setting a record close for the fifth day in a row. And more gains in media stocks. Warner Brothers up another 17 percent on expectations. Paramount Skydance will make a bid for the company as soon as next week. Shares surging nearly 30 percent yesterday when the news first broke. Meantime, vaccine makers getting hit hard and reports that Trump administration officials will link 25 child deaths to COVID shots during a key vaccine panel meeting next week.

27:07Pfizer down 4 % while Moderna fell by more than 7%. Novavax and BioNTech also down sharply. For the very latest, let's get to Angelica Peebles. Angelica. Hey, Melissa. Well, NBC is reporting that health officials are planning to present their findings next week at the CDC's Vaccine Advisory Committee meeting. Now, we don't have an agenda or any presentations for that meeting yet, and typically those materials are posted in advance to give the public time to review them. We do know that the committee plans to weigh who should get a COVID shot this fall, with the FDA already approving boosters for a narrower group of people than we have seen in years past.

27:42Whether children need COVID vaccines, of course, has been a big focus of this administration. Just last week, FDA Commissioner Marty McCary said that the FDA was investigating reports of children who died after receiving a COVID vaccine. But an HHS spokesperson says the FDA and CDC routinely analyze data from a federal vaccine safety database and those reviews are being shared publicly but until that happens any of this should be considered pure speculation. Moderna meanwhile standing by the safety of its COVID vaccine saying that it's rigorously reviewed by the company and regulators around the world who haven't found any new or undisclosed safety concerns in children or pregnant women with more than one billion doses distributed.

28:24So much more to come next week Melissa. The American Academy of Pediatrics Angelica, and correct me if I'm wrong, already they do recommend COVID shots for 23 months, so I think six years. So we're talking about a smaller group, right, that would potentially be affected by the change in recommendations? Right. So already, though, we have seen changes to those recommendations. The FDA approving the COVID shots for narrower groups, saying that really, in terms of the youngest children, you shouldn't get one unless you have a comorbidity. Now, exactly how the ACIP weighs in is still something that's on the horizon that we have to see.

29:01And then the question becomes, will doctors prescribe it sort of off-label? Will they start, you know, giving the COVID vaccines to kids no matter what? And then whether insurers will cover it. So there's a lot more to come here. And I think, you know, this is really interesting because, of course, this has been such a flashpoint. But at the same time, last year, only 13 percent of kids that were eligible for COVID booster got one. So this is such a heated political issue. But really, when we think about the overall impact, it's probably going to be a lot smaller than that. But this could be something to watch in terms of what happens with other vaccines.

29:34And as we start sort of going through that immunization schedule for children that the HHS and the secretary have talked about going through. So definitely one to watch still. Angelica, thanks. Angelica Peebles. For more, let's bring in BMO, head of health care research, Evan David-Siegerman. Evan, great to have you with us. How do you think about this in terms of the impact on other vaccines, as Angelica pointed out? Well, I think this general anti-vaccine rhetoric is not great for public health. You know, as Angelica said, the COVID vaccine for kids is such a small portion of the current sales.

30:09I don't even model it out in my Pfizer and BioNTech models for what it's worth. Really, the bulk of my sales are contracted outside of the United States. And, of course, for folks who are older folks who are at risk in the United States. But it's this vaccine rhetoric that just has a cascading effect to HPV, MMR, all the vaccines that kids usually get. And, of course, this rhetoric out of Florida isn't great either. It seems like it would be key to see what insurers do if insurers decide ultimately to still pay for vaccines, despite what ACIP, the committee that approves vaccines, despite what ACIP recommends.

30:48I mean, are you looking at that as sort of key to understanding how their recommendations will be viewed? For sure. And I think the insurance coverage and also the availability to get a vaccine just from a pharmacist without a prescription is really important as well. You know, I don't see, you know, the MMR, the HPV, all these kind of common vaccines being taken away or not insured. I think that would actually probably cause some backlash. I think the COVID vaccine is a bit of a flashpoint. There's a push and pull saying there's not enough data. And I really it just seems like more of a political push versus, you know, something that's actually a public health problem.

31:27I mean, the diseases are public health problems, but, you know, the use of the vaccines are not. Ernest Karens, thanks for being on. So to further that point, do you think regardless how this particular thing plays out that still these there's such a headwind against, you know, Moderna and Pfizer? Well, I think, you know, so for BioNTech and Pfizer, for example, I mean, Moderna's whole business is COVID. Pfizer, obviously, much more diversified. It's an incredible and it's a shrinking part of the business. So there are other issues that Pfizer is dealing with. You know, we're looking at their LOEs.

32:03What are they going to acquire? Their whole oncology franchise. With BioNTech, COVID is part of the revenue component. But a lot of the go forward is what they're doing on oncology. recall that they have a big partnership with Bristol-Myers for the PD-L1, VEGF, by specific lung cancer. So from an investor perspective, you know, the focus is shifting away from vaccines. But from a headline perspective, a day like this really shows that investors get a little jittery or the generalists get a jittery and they're not thinking about kind of what else these businesses have. Evan, while we have you, we are on the eve of a big diabetes meeting in Europe over the weekend and next week.

32:38And I'm wondering what are the key days, the key presentations, readouts that you're looking for? So I think the biggest is, of course, the Orphaglipron data, which I came on mid-August. We spoke about, we're going to learn more about what happened with that, why did it underperform, and most importantly, what clinicians are saying about that. I think if I were to look at this whole event, I really want to understand, is that 11%, 12 % good enough? Do I need that 16 %? What is an acceptable nausea and vomiting rate? And then also, So what about the food effect? We talked about that when it came to high-dose oral semaglutide as a potential headwind for Novo Nordisk.

33:18And is that a real issue that clinicians see if and when they use this in the real world? All right. Evan, thanks. Evan David Siegerin of BMO. All right. You own Pfizer. Yeah. I think Pfizer's largely been de-risked. I appreciate the pointing out just what and how at least a slowing significance, a lower significance in terms of vaccines of COVID's business model. Their CGN acquisition is providing a lot of opportunity. Oncology is providing a ton of opportunity for the company. If you look at it on a PE multiple, if you look at a 6 percent dividend yield, maybe not a reason to buy a company, maybe a reason to buy this one.

33:54I think you're well paid to hang in there for a company that's been de-risked. And I don't you know, again, it's I thought I was buying this thing when we had gotten all the bad news on vaccines out of it a couple of years ago. Apparently not. But, you know, I think you've priced in the vaccine dynamics. I mean, Pfizer has attempted to bottom and then come to life and then faltered and come to life. There are traps and it just has that feel to it. We do have a news alert on Fed Governor Lisa Cook. Megan Cassell's got the details there. Megan. Melissa, that's right. New documents here in that ongoing case surrounding Lisa Cook and her various mortgages.

34:33Reuters is reporting now that they have seen a document, a loan estimate from 2021, that they say shows Cook declared her Atlanta home would be a vacation home. Now, this appears to undercut fraud claims from the Trump administration, as they say that she had tried to list that Atlanta home in addition to a Michigan home, listing both of them as her primary residences. Now, Reuters says they've seen this document that shows she had listed from the start the Atlanta home as a vacation home. So it appears, again, to undercut those claims of fraud. Reuters says they tried to reach Cook for comment on this and weren't able to reach her, but we should note she has repeatedly denied any wrongdoing in this case.

35:12They also say that some secondary documents could also help Cook's case that they reviewed here, that's saying that she never requested a tax exemption for the Georgia home as a primary residence. They say that's according to property records, and to a Fulton County tax official here. So, Melissa, as this case progresses, just appears now to be some documents, according to Reuters, reviewed by Reuters, that shows she did not list her Georgia home as a primary residence. All right, Megan, thanks. Megan Casella. Coming up, it was a call heard around the world, Dan Nathan getting bullish on Tesla, on the technicals last night.

35:45And now we've got the Chartmaster plugging in, where he sees that stock heading next. Fast Money back in two.

36:00Welcome back to Fast Money. Shares of Tesla up another 7 % today, gaining nearly 12 % since Monday. That's the stock's best week since May. Now, just yesterday, our perma bear Dan Nathan said he'd turn all silver linings on this one. I think there's really something interesting that's going on in the stock of late. The bulls and the bears agree that the EV business is bad. I think the consensus for Q3 deliveries is probably low. I think there's probably been a pull forward if you think about that$7 ,500 tax credit that's going away at the end of the month. And look at how this stock, we just want to pull the chart up here.

36:34It looks like it's a beneficiary of this rotation. Let's see what the chart master says about the stock now, now that it's up 13 % since Monday. Do you agree? Did you agree with that premise that the stock chart was looking better? Well, sure. I mean, let's just talk about it. So we did a poll, institutional clients, on Monday, August 18th, and it came back 69 % bullish, so 70-30. The stock was trading at maybe 330. It's 395 now. We're up almost 20 % from that point. We have two charts here. At this point, it has broken out from the wedge it's been in. This is the before. You see it there, converging trend lines.

37:14It spiked post-election. It was a trap, drops 50%, and now it's in the apex. The second chart of the two, it has moved out of that apex. So you have a big move out of the formation. Typically, that's bullish, and you can get some follow-through. But hour-to-hour, day-to-day, it has a bit of a pile-on. There's a lot of people sort of embracing something that was dormant, and that's what makes people want to buy, which is good technique. After something moves, you want to go after it. But it's up quite a bit, and I think at this point, I would sell calls or hedge longs. What would you do as a trade?

37:45We know you don't like the stock. Yeah, I think we've seen rotation into different parts of tech. Tesla's been unloved for a long time. It should have been unloved. The stock, even before two days ago, had rallied almost 60 % off the April low. So as Kars pointed out, it's not like this has just suddenly turned around. I mean, this stock has had a pretty good run. And as we talked about fundamentally, kind of even before the election spike, this was a company that no one was expecting any good news on from the analyst community, at least on deliveries, until 3Q of 25. So, again, where are expectations?

38:22Dan's point is, hey, if both sides of the equation are now pretty much in harmony, that the EV business is awful, maybe that's a good reason. But anyway, I'm not chasing this one here. How about, as they say? Part of this momentum, at least, is also the notion that people are going to rush to go buy cars to get that$7 ,500 tax credit, which, though, is also benefiting EV makers across the board, whether it be pure EV makers or a GM, I would imagine. Yeah, who are buying those credits. Right, exactly. Well, I don't know if some of the foreign credits, foreign may be manufactured here, but foreign plates get that tax credit here.

39:01I don't know. The Tesla thing, Dan being bullish, I do find hilarious, and I wonder if you'll see that clip and think, That is an AI. Somebody just made that up. No, I believe you. It's real. We witnessed it, right? Tim and I were here. Yeah. We saw it in the past. It was not AI Dan. It was not AI Dan. We thought we should play it instead of just paraphrasing because I think that it would be, you know, completely unbelievable to some of our viewers who might have missed the show yesterday. One thing about this, it's just a beta trade, right? I mean, after the election, it was up 130 percent more than Mark.

39:31On its lows of the sort of tariff swoon, it was down 58 percent. Now it's up 85 percent from the tariff load. to Tim's point. It's a momentum stock, which is loved and hated, but it's had a big move. But like a lot of things in life, I mean, good for Dan for changing the view. And actually, I mean, that's important stuff as a trader. Coming up with Dine-In or taking out, restaurants are leaning into different strategies to lure customers back and who's going high end and who's searching for value. That's next. And do not forget, grab your tickets for the next Fast Money Live. That's December 11th.

40:04Scan a QR code on your screen. Head to CNBCEvents.com slash fast money. We're trading the holidays. Fast money is back in tune.

40:19Welcome back to Fast Money. Restaurant spending ticked up slightly in August, but with consumers still under pressure, restaurant CEOs are forced to make a choice, double down on value or go all in on premium. Kate Rogers, more on this. Kate. Hey, Melissa. So restaurant spending, as you said, ticked up slightly in August, up 3.7 percent. That's according to data from Bank of America. But strategies amongst major brands are proving to vary. I chatted with several executives this week across coffee, fast casual and casual dining who seem to either take the deep discounting value path or the premium path.

40:50Rob Lynch, Shake Shack CEO, talked with me about the company's new French onion soup menu, saying they have about 18 months of limited time offers lined up. Many premium offerings that guests can opt into if they choose, but they're also offering some deals in the Shack app. John Payton, Dinebrand CEO, said the company is seeing value get people in the door, but they're buying less off of the value menu rather than they were before. And then Brian Nickel told me that Starbucks is a premium experience, and he believes it's correctly priced in this environment. Take a listen to both of those executives.

41:22Our value offerings are clearly driving traffic into the restaurants, but the guests are exploring the full menu once they're there. I do believe we are a premium brand, and I do believe you get a premium experience with the Green Apron service model. Now, Nickel also said they've removed a lot of discounting from the menu because it wasn't effective for that company. And, Melissa, this comes, of course, as McDonald's once again leaning even further into value with those combo meals. That'll be about 15 percent less for people if they were to buy them off the combo meal menu versus what they'd pay individually for those items.

41:56Back over to you. I can't imagine what the margins are on French onion soup. I mean, it's got to be huge. I mean, a bag of onions costs how much? Nothing. Well, the burger, too, remember, it's about$10.99, right? It's another premium option for people that they can opt into. But he's saying, you know, it helps get people in the door. They can opt in, but they don't have to buy it if they come to Shake Shack. French onion menu. Kate, thanks. Kate Rogers. Thank you. You're a Starbucks shareholder? It's a premium brand. Definitely. And I think they're doing a nice job of making people feel like they're appreciated and there's a customer service element.

42:31I think it's all great. I worry a little bit about the competitive landscape and the margin profile. And, you know, same store sales, you know, U.S. have been difficult. Chipotle really looks like a dangerous stock to own here. And it looks like there's been such a great growth story and a higher multiple. It's been paid. Clearly, that's not a terrible chart. Up next, final trades.

43:03Final trade time, Tim. That was close for a sample scan. We don't have a lot of time. Disney, let's do that. Karen. Yes, after a very big run, put on some Google collars today. I'm in agreement with Carter on that one. Carter Braxton Worth. Sunoco products, containers, and packaging making a turn. Bear to bull. along with Monroe Muffler. Educational show tonight. Thanks for watching Fast. See you back here on Monday. Mad Money at Jim Cramer starts right now.

43:52podcast as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion. Such opinions are based upon information the Fast Money participants consider reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. To view the full Fast Money disclaimer, please visit cnbc.com forward slash Fast Money disclaimer.

From the publisher

Apple postponing the launch of its new iPhone Air model in China, as regulatory issues hit the tech giant. How they’ll clear that hurdle, and what a top tech analyst sees in store for the stock after a muted Apple event response. Plus A new report threatening vaccine makers, as the Trump admin takes aim. The connection they’re linking the group to, and what it means for the space going forward.

Fast Money Disclaimer


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More from CNBC's "Fast Money"

All 871 episodes
Apple’s Device Delay… And Vaccine Makers Under Pressure 9/12/25CNBC's "Fast Money" · 44 min
Listen in VO